What is the correct statement regarding pre-test counseling for a patient being screened for STIs and BBVs, including HIV and Hepatitis C?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pre-Test Counseling for STI and BBV Screening: Important Facts

People with HIV who receive antiretroviral treatment and maintain an undetectable viral load do not sexually transmit HIV to an HIV-negative partner.

Key Points About STI and BBV Testing and Counseling

HIV Transmission and Treatment

  • Individuals with HIV who adhere to antiretroviral therapy (ART) and maintain an undetectable viral load effectively eliminate the risk of sexual transmission of HIV 1
  • Multiple observational studies of serodiscordant couples have confirmed that successful ART dramatically reduces HIV transmission risk 1
  • The PARTNER Study, which included both heterosexual and same-sex male couples, reported zero HIV transmissions over an estimated 894 couple-years of observation when the HIV-positive partner was on ART with an undetectable viral load 1

Partner Notification and Legal Responsibilities

  • Partner notification is not exclusively handled by health departments; healthcare providers should advise patients to notify their sex partners of STI exposure 1
  • The process can involve:
    • Patient referral: Patients notify partners themselves
    • Contract referral: Patients agree to notify partners within a defined timeframe, with health department follow-up if this doesn't occur
    • Provider referral: Health department staff directly notify partners 1
  • Health department notification of communicable diseases is the legal responsibility of healthcare providers, not patients 1

Hepatitis C Facts

  • Hepatitis C is NOT an incurable disease 2, 3
  • Current treatments for hepatitis C can achieve cure rates exceeding 95% with direct-acting antiviral medications
  • Sexual transmission of HCV is uncommon in HIV-negative individuals, with studies showing low incidence rates (0.7 per 100 person-years) even among those with high rates of other STIs 2

Pre-Test Counseling Best Practices

Essential Components

  1. Personalized risk assessment - Evaluate specific risk behaviors and tailor prevention messages accordingly 1
  2. Explanation of test results - Clearly explain what positive and negative results mean 1
  3. Informed consent - Ensure patient understands and agrees to testing 1, 4
  4. Development of risk reduction plan - Help patient create a realistic plan to reduce HIV/STI risk 1

Communication Approaches

  • Use open-ended questions and non-judgmental language 1
  • Provide explicit, clear information when discussing test results 1
  • Avoid excessive technical discussions about "window periods" that might confuse the patient 1
  • Ensure privacy and confidentiality throughout the counseling process 1

Post-Test Considerations

  • Arrange for appropriate follow-up and linkage to care for those with positive results 1
  • For those with ongoing risk, discuss prevention strategies including PrEP if appropriate 4
  • Provide information about partner notification procedures 1

Common Pitfalls to Avoid

  • Assuming low risk: Don't assume patients are at low risk based on demographics or self-reported behaviors
  • Inadequate follow-up: Failure to link patients with positive results to appropriate care reduces the benefit of testing 1
  • Overwhelming with information: Focus on key messages rather than technical details that might confuse patients 1
  • Neglecting partner notification: Ensure patients understand the importance of partner notification and available assistance 1

Remember that effective pre-test counseling should be client-centered, focused on risk reduction, and should provide clear information about the testing process and potential results.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2022

Research

Viral hepatitis: a sexually transmitted disease?

Nurse practitioner forum, 1996

Guideline

HIV Diagnosis and Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.